Valuation
- The stock trades at elevated absolute P/E multiples (TTM: 28.83x, Forward: 43.62x) which are justified by the company's high growth rate, market leadership, and financial performance. The PEG ratio suggests potential value, and the stock is not overvalued relative to its quality and growth profile, with a fundamental-based target price of $302.
- Current Price: $250.02 (as of 2026-06-03 close).
- P/E (TTM): 28.83x. This is elevated compared to the market average but must be contextualized against the company's high growth rate.
- Forward P/E (Dynamic): 43.62x. This higher multiple likely reflects market expectations for continued strong earnings growth beyond the TTM period.
- P/B Ratio: 5.45x. This premium to book value is justified by the company's exceptionally high ROE (23.59%).
- P/S Ratio (TTM): 3.62x. This is reasonable for a high-margin, high-growth market leader in its sector.
- A crude PEG ratio using recent net profit growth of 76.65% is very low (~0.38), suggesting the stock is cheap relative to its recent growth.
- Using a more normalized growth expectation (31.09%), the PEG ratio is approximately 0.93, still indicating potential value.
- The stock has traded between approximately $199.14 and $278.56 over the last 60 days, with a recent pullback to $250.02.
- Based on strong fundamental trajectory, the stock does not appear overvalued relative to its quality and growth profile.
- Reasonable 12-Month Price Range: $285 - $320. Fundamental-Based Target Price: $302.